Allscripts Announces Per Share Amount of Special Cash Dividend of $5.23
As of the close of business on the record date for the special cashdividend, holders of approximately $54.6 million aggregate principal amount ofAllscripts' 3.50% Convertible Senior Debentures elected to convert into sharesof Allscripts common stock.
Allscripts is the leading provider of clinical software, connectivity andinformation solutions that physicians use to improve healthcare. The company'sunique solutions inform, connect and transform healthcare, delivering improvedcare at lower cost. More than 40,000 physicians and thousands of otherhealthcare professionals in clinics, hospitals and extended care facilitiesnationwide utilize Allscripts to automate everyday tasks such as writingprescriptions, documenting patient care, managing billing and scheduling, andsafely discharging patients, as well as to connect with key information andstakeholders in the healthcare system. To learn more, visit Allscripts athttp://www.allscripts.com
This communication contains forward-looking statements. Those forward-looking statements include all statements other than those made solely withrespect to historical fact. Forward-looking statements may be identified bywords such as "believes," "expects," "anticipates," "estimates," "projects,""intends," "should," "seeks," "future," continue," or the negative of suchterms, or other comparable terminology. In addition, statements made in thiscommunication about anticipated financial results, future operationalimprovements and results or conditions and approvals are also forward-lookingstatements. Such forward-looking statements are subject to numerous risks,uncertainties, assumptions and other factors that are difficult to predict andthat could cause actual results to vary materially from those expressed in orindicated by them. Such factors may include, but are not limited to: (1) theoccurrence of any event, development, change or other circumstances that couldgive rise to the termination of the merger agreement; (2) the outcome of anylegal proceedings that have been or may be instituted against Allscripts,Misys or MHS and others; (3) the inability to complete the proposedtransaction due to the failure of any party to satisfy other conditions tocompletion of the proposed transaction; (4) risks that the proposedtransaction disrupts current plans and operations and potential difficultiesin employee retention as a result of the merger; (5) the ability to recognizethe benefits of the merger; (6) legislative, regulatory and economicdevelopments; and (7) other factors described in filings with the Securitiesand Exchange Commission. Many of the factors that will determine the outcomeof the subject matter of this communication are beyond Allscripts' ability tocontrol or predict. Allscripts can give no assurance that any of thetransactions related to the merger will be completed or that the conditions tothe transactions will be satisfied. Allscripts undertakes no obligation torevise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events orotherwise. Allscripts is not responsible for updating the informationcontained in this communication beyond the published date, or for changes madeto this communication by wire services or Internet service providers.
SOURCE Allscripts Healthcare Solutions, Inc.
You May Also Like